about
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).WSES Guidelines for the management of acute left sided colonic diverticulitis in the emergency settingThe role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paperPancreatic Cancer Diagnostics and Treatment--Current StatePremalignant and malignant lesions of the heterotopic pancreas in the esophagus: a case report and review of the literature[Influence of the Weather on the Incidence of Fractures in the Elderly].Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferenceA proposal for a CT driven classification of left colon acute diverticulitis.28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study.Global validation of the WSES Sepsis Severity Score for patients with complicated intra-abdominal infections: a prospective multicentre study (WISS Study).Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions.[Skin and soft tissue infections (SSTIs)].[Our experience with pancreatic cancer and its relation to diabetes mellitus].[Basic principles of diagnosis and treatment of secondary peritonitis - recommendations of experts with the support of SIS].[Laparoscopic surgery in senior age][Current status of pancreatic cancer diagnosis][The development of surgical treatment in liver and biliary tract diseases][Idiopathic inflammatory bowel disease - advancements in surgical treatment][Cystic tumors of the pancreas - - our experience with diagnostics]The frequencies of six important thrombophilic mutations in a population of the Czech Republic
P50
Q26739860-40759AEF-4580-4533-AF18-52C4DBB3A1DBQ26740358-649B04B8-2D99-439F-B55F-0B2E56381216Q26798276-AFEDEFD3-3755-453F-BB50-8E08085129E3Q26864044-9EE3BAB9-343C-40C1-84E8-CED679D56766Q27004599-CDE9A4B6-7335-427B-8B75-FAB564EA9609Q33469507-E8DF3EA0-D5B6-475F-85CD-72232D7232A8Q33640559-66F12F70-1A2B-418A-B269-4BB01BD88078Q35599250-C7544915-B65D-49EF-9F27-25F83CF3333FQ35980481-EB33489B-1545-409A-BE7C-0301852842A2Q36376512-3A4FDB75-123E-4AC2-AF78-BFB56A67DC06Q38775352-EC8C22CF-ECAE-4547-A1EC-D7FD1D574370Q40659276-0FB910B9-163A-44E3-BBF3-F1010FB79D37Q42956537-4B559E70-BDCF-4E34-B547-953E38041319Q45286773-B09E2674-05A3-4D2F-BC79-E5C9E755C5F1Q50182372-B259C046-E9B1-47DD-A003-CC0F694C9C9BQ83366955-04E95919-EDB3-458F-83FB-E43E3C0C592AQ85441580-62971CED-DA02-40E7-A913-B1C46FBE67D2Q85462749-DE15F72F-A751-45D6-B52F-54C01FACE488Q95396880-137592D3-D72C-44FB-BA94-7597C4A653AFQ95510252-C7E1EC44-0558-4D6D-8FBD-5F79A77A4850
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jan Ulrych
@ast
Jan Ulrych
@en
Jan Ulrych
@es
Jan Ulrych
@nl
type
label
Jan Ulrych
@ast
Jan Ulrych
@en
Jan Ulrych
@es
Jan Ulrych
@nl
prefLabel
Jan Ulrych
@ast
Jan Ulrych
@en
Jan Ulrych
@es
Jan Ulrych
@nl
P106
P1153
25622846800
P31
P496
0000-0002-5225-9562